Key points are not available for this paper at this time.
Determination of ACE2 activity may provide a new and important diagnostic and prognostic marker for patients with CD. ACE2 activity and BNP concentration have additive predictive value and may be used in combination to offer a new dimension of prediction in HF.
Kathryn S. Hoff (Fri,) studied this question.